Healthcare Information Services Stocks Under Scanner -- Rennova Health, Cerner, Veeva Systems, and WebMD Health

Tuesday, January 31, 2017 General News
Email Print This Page Comment

NEW YORK, January 31, 2017 /PRNewswire/ --

On Monday, January 30, 2017, the NASDAQ

Composite ended the trading session at 5,613.71, down 0.83%; the Dow Jones Industrial Average edged 0.61% lower, to finish at 19,971.13; and the S&P 500 closed at 2,280.90, down 0.60%. Losses were broad based as all nine sectors within the US markets
ended the day in negative. This Tuesday, Stock-Callers.com has initiated reports coverage on the following Healthcare Information Services equities: Rennova Health Inc. (NASDAQ: RNVA), Cerner Corporation (NASDAQ: CERN), Veeva Systems Inc. (NYSE: VEEV), and WebMD Health Corporation (NASDAQ: WBMD). Learn more about these stocks by downloading their free research reports in PDF format at:

http://stock-callers.com/registration

Rennova Health  

On Monday, shares in West Palm Beach, Florida headquartered Rennova Health Inc. ended the session 17.35% lower at $0.07, with a total trading volume of 21.61 million shares. Shares of the Company, which provides diagnostics and supportive software solutions to healthcare providers, are trading at a PE ratio of 0.06. The stock is trading 28.12% below its 50-day moving average and 78.18% below its 200-day moving average. Moreover, the Company's shares have a Relative Strength Index (RSI) of 39.32. Sign up and read the free research report on RNVA at:

http://stock-callers.com/registration/?symbol=RNVA

Cerner  

On Monday, shares in North Kansas City, Missouri headquartered Cerner Corp. recorded a trading volume of 2.03 million shares. The stock ended the day 0.15% lower at $52.94. Shares of the Company, which designs, develops, markets, installs, hosts, and supports health care information technology, health care devices, hardware, and content solutions for health care organizations and consumers in the US and internationally, are trading at a PE ratio of 28.03. Cerner's stock has gained 11.52% in the past one month. The Company is trading above its 50-day moving average by 7.07%. Furthermore, Cerner's shares have an RSI of 64.55.

On January 19th, 2017, research firm Barclays downgraded the Company's stock rating from 'Overweight' to 'Equal Weight' while revising its previous target price from $63 a share to $52 a share. The complimentary research report on CERN can be downloaded at:

http://stock-callers.com/registration/?symbol=CERN

Veeva Systems  

Pleasanton, California headquartered Veeva Systems Inc.'s stock finished Monday's session 1.38% lower at $42.06, with a total trading volume of 442,879 shares. Over the last one month and the previous three months, Veeva Systems' shares have gained 1.84% and 11.42%, respectively. Furthermore, the stock has rallied 74.52% in the past one year. The Company's shares are trading above its 200-day moving averages by 12.19%. Shares of Veeva Systems, which provides industry cloud software and data solutions for the life sciences industry in North America, the European Union, Asia/Pacific, and internationally, are trading at a PE ratio of 90.06. The stock has an RSI of 39.54. Register for free on Stock-Callers.com and access the latest report on VEEV at:

http://stock-callers.com/registration/?symbol=VEEV

WebMD Health  

New York headquartered WebMD Health Corp.'s stock advanced 2.53%, to close the day at $49.45. The stock recorded a trading volume of 1.09 million shares, which was above its three months average volume of 877,850 shares. The Company's shares are trading 4.25% and 11.23% below its 50-day and 200-day moving averages, respectively. Shares of the Company, which provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms, and health-focused publications in the US, are trading at a PE ratio of 27.91. Additionally, the stock has an RSI of 41.28.

On January 30th, 2017, research firm Citigroup upgraded the Company's stock rating from 'Neutral' to 'Buy'. Get free access to your research report on WBMD at:

http://stock-callers.com/registration/?symbol=WBMD

--

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://stock-callers.com/legal-disclaimer/

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: info@stock-callers.com Phone number:  +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook